| Marc Jacobson, DDS | |
|
10521 N Port Washington Rd, Mequon, WI 53092-5584 | |
| (262) 241-2060 | |
| (262) 241-2064 |
| Full Name | Marc Jacobson |
|---|---|
| Gender | Male |
| Speciality | Dentist |
| Location | 10521 N Port Washington Rd, Mequon, Wisconsin |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1043479827 | NPI | - | NPPES |
| 33412900 | Medicaid | WI |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 122300000X | Dentist | 2475-015 (Wisconsin) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Marc Jacobson, DDS 10521 N Port Washington Rd, Mequon, WI 53092-5584 Ph: (262) 241-2060 | Marc Jacobson, DDS 10521 N Port Washington Rd, Mequon, WI 53092-5584 Ph: (262) 241-2060 |
News Archive
Obesity is a global health problem. The number of people who are obese is staggering, with more than 1.9 billion overweight people, and over 650 million who are obese in 2016. That number has tripled since 1975. In 2016, about 40 percent of all adults in the country, which accounts for approximately 93 million individuals, had obesity.
Global regenerative medicine company, Mesoblast Limited, (ASX: MSB), today announced that it had received clearance from the European Medicines Agency (EMA) to begin a 225-patient multi-center Phase 2 clinical trial in Europe for its lead cardiovascular product Revascor™ in conjunction with angioplasty and stent procedures to prevent heart failure after a major heart attack. Revascor™ is an allogeneic, or "off-the-shelf", adult stem cell product derived from Mesoblast's proprietary Mesenchymal Precursor Cell (MPC) platform technology which is being developed for use in a range of cardiovascular diseases including congestive heart failure, chronic angina, and heart attacks (acute myocardial infarction).
With cancer survival rates in the UK persistently trailing comparable European countries, it's time to admit to a national problem – and do something about it, says a leading expert at the Primary Care Society for Gastroenterology.
Advanced Life Sciences Holdings, Inc., a biopharmaceutical company engaged in the discovery, development and commercialization of novel drugs in the therapeutic areas of infection, oncology and respiratory diseases, announced today that the U.S. Food and Drug Administration has provided guidance on the clinical program required to assess the approvability of Restanza™ (cethromycin), a novel oral once-a-day antibiotic, in the treatment of outpatient community acquired bacterial pneumonia (CABP) as well as biodefense indications including anthrax, plague and tularemia.
› Verified 7 days ago
Dr. Gargi Bhagavatula, D.D.S. Dentist Medicare: Not Enrolled in Medicare Practice Location: 6048 W Mequon Rd, Mequon, WI 53092 Phone: 402-213-6077 | |
Dr. Taylor Leann Dumez, DMD Dentist Medicare: Not Enrolled in Medicare Practice Location: 11501 N Port Washington Rd Ste 102, Mequon, WI 53092 Phone: 262-241-8880 Fax: 262-241-5250 | |
Dr. John C. Kittleson, D.D.S. Dentist Medicare: Not Enrolled in Medicare Practice Location: 10521 N Port Washington Rd, Mequon, WI 53092 Phone: 262-241-3141 | |
Dr. Julia Lynn Snell, DDS Dentist Medicare: Not Enrolled in Medicare Practice Location: 11501 N Port Washington Rd Ste 102, Mequon, WI 53092 Phone: 262-241-8880 | |
Dr. Stephan William Klug, DDS Dentist Medicare: Not Enrolled in Medicare Practice Location: 1017 W Glen Oaks Lane, Suite 211, Mequon, WI 53092 Phone: 262-241-4440 Fax: 262-241-3331 | |
Dr. Don Anthony Stoiber, DDS Dentist Medicare: Medicare Enrolled Practice Location: 10303 N Port Washington Rd, Suite #103a, Mequon, WI 53092 Phone: 262-240-0405 Fax: 262-240-0434 |